SBSakib Burza

Sakib Burza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sakib Burza has a total of 315 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Resurgence of Malaria in Protected and Rural Areas After Successful Control Program in a Brazilian Amazon Municipality

    by E. B. Skinner, D. de Angeli Dutra, É. Pelegrino, O. Damasceno, S. Burza, E. A. Mordecai

    Malaria eradication requires reducing transmission in endemic areas and maintaining these reductions in areas where elimination has been achieved. In Altamira, a municipality in the Xingu Basin of the Brazilian Amazon, a malaria control program was implemented during the construction of the Belo Monte Dam which eliminated local malaria cases, but resurged in rural areas after these efforts ceased. To elucidate different drivers of malaria transmission in Altamira, before (2006–2012) and after (2017–2020) the construction of Belo Monte Dam and the localized malaria control program, we analyzed annual notified malaria cases alongside geospatial variables including forest edge, population size and travel time to urban centers. Due to the low incidence, malaria case data was clustered based on the geographic proximity of health centers. A total of 17,578 malaria cases were reported in Altamira between 2006 and 2020. Malaria cases exceeded 1,200 per year prior to dam construction, then dropped below 100 during construction, resurging to over 700 cases by 2020 predominantly in rural clusters. Using generalized additive models we found that malaria cases increased significantly with increases in forest edge habitats and local population size, both before and after dam construction, while neither distance to deforestation nor climatic variables explained incidence variation. This study emphasizes that interruptions to control efforts, even when localized, can rapidly reverse gains, and that understanding landscape epidemiology is critical for achieving and maintaining malaria elimination in Amazonian settings.

  • Open Access

    Predicting referral need for febrile children in low-resource community settings in South and Southeast Asia

    by Arjun Chandna, Constantinos Koshiaris, Raman Mahajan, Riris Adono Ahmad, Dinh Thi Van Anh, Khalid Shams Choudhury, Suy Keang, Nguyen The Nguyen Phung, Sayaphet Rattanavong, Souphaphone Vannachone, et al.

    In resource-constrained community settings, identifying which febrile children require referral remains a major unmet need. Current World Health Organization (WHO) danger signs have limited accuracy, resulting in missed severe illness and unnecessary referrals. Here we developed and validated clinical prediction models to support referral decisions using data from 3,405 children aged 1−59 months presenting with community-acquired acute febrile illnesses to seven hospitals across Bangladesh, Cambodia, Indonesia, Laos and Vietnam. Cambodian data were held out for external validation. The model using simple clinical parameters (sensitivity 74.7% (95% confidence interval (CI): 59.4−88.1); specificity 99.1% (95% CI: 97.7−99.7)) outperformed WHO criteria (sensitivity 55.5% (95% CI: 39.4−72.7); specificity 82.6% (95% CI: 77.1−87.6)) for identification of children at risk of severe disease (death or organ support within 2 days). Including either pulse oximetry or the host biomarker soluble TREM1 (sTREM1) increased sensitivity to 88.9% (95% CI: 76.7−97.8; pulse oximetry) and 89.2% (95% CI: 76.9−97.5; sTREM1), respectively. The pulse oximetry-based model achieved these gains with a threefold reduction in referral rates. These approaches appear cost-effective (pulse oximetry incremental cost effectiveness ratio (ICER) = $26.28; sTREM1 ICER = $196.46) and could improve triage for febrile illness in low-resource settings by enabling more accurate referral decisions. They warrant evaluation in community-based trials.


  • Open Access

    Consumer acceptance of black soldier fly (BSF) larvae-based products in rural south-east Madagascar

    by Vonimihaingo Ramaroson, Sabrina Simon, Brian L. Fisher, Sakib Burza

    Edible insects are gaining attention as sustainable protein sources. In Madagascar, where malnutrition and stunting are prevalent, entomophagy is traditional, yet the Black Soldier Fly is not commonly consumed. This study aimed to assess consumer acceptance of three Black Soldier Fly larvae-based products in rural Madagascar (whole larvae, BSF powder, and crackers containing BSF powder), using a white bean soup meal as a virtual control. Further, we intended to identify cultural, sensory, and psychological factors influencing acceptance before and after consumption. A mixed-methods approach combining surveys and focus group discussions was conducted among seventy households from seven villages around the Manombo Special Reserve, a rainforest-dwelling community in south-east Madagascar. Participants exhibited moderate food neophobia (33.78 ± 1.22). Of these, 92% reported having eaten insects, and 88.1% did not consider insect food disgusting. Over half believed that insect consumption offers significant advantages, whereas a minority (9%) expressed concerns about microbes, poisons/toxins, or allergies. Among the tested products, crackers containing BSF powder were most preferred across all sensory criteria (appearance, smell, taste, texture), while whole larvae were least accepted, often rejected due to visual disgust, odour, and difficulty swallowing. Powder received moderate acceptance. 95 and 79% of children liked the crackers and powder, respectively, 84% of children consumed all three products offered to them. Lack of familiarity was cited as a key barrier to acceptance of the larvae; however, providing information about the origin and benefits of BSF was suggested as a means of improving perceptions. Future initiatives should focus on promoting processed BSF products, targeting children for early adoption, and investing in educational programmes that demystify production while highlighting nutritional and environmental benefits.


  • Open Access

    Resurgence of malaria in protected and rural areas after successful control program in a Brazilian Amazon municipality

    by Eloise B Skinner, Daniela de Angeli Dutra, Érika Pelegrino, Osvaldo Damasceno, Sakib Burza, Erin Mordecai

    Malaria eradication requires reducing transmission in endemic areas and maintaining these reductions in areas where elimination has been achieved. In Altamira, a municipality in the Xingu Basin of the Brazilian Amazon, a malaria control program was implemented during the construction of the Belo Monte Dam which eliminated local malaria cases, but resurged in rural areas after these efforts ceased. To elucidate different drivers of malaria transmission in Altamira, before (2006-2012) and after (2017-2020) the construction of Belo Monte Dam and the localized malaria control program, we anlayzed annual notified malaria cases alongside geospatial variables including forest edge, population size and travel time to urban centres. Due to the low incidence, malaria case data was clustered based on the geographic proximity of health centers. A total of 17,578 malaria cases were reported in Altamira between 2006 and 2020. Malaria cases exceeded 1,200 per year prior to dam construction, then dropped below 100 during construction, resurging to over 700 cases by 2020 predominantly in rural clusters. Using generalized additive models we found that malaria cases increased significantly with increases in forest edge habitats and local population size, both before and after dam construction, while neither distance to deforestation nor climatic variables explained incidence variation. This study emphasizes that interruptions to control efforts, even when localized, can rapidly reverse gains, and that understanding landscape epidemiology is critical for achieving and maintaining malaria elimination in Amazonian settings.

  • Open Access

    Water quality and hydrologic connectivity in rural communities around the Manombo Special Reserve of southeastern Madagascar during the dry season

    by Ryan Parks, Julia Kagiliery, Walter Tianjanahary, Andry Tsirimanana, Sakib Burza, Ryan Emanuel, Brian G. McAdoo


  • Open Access

    Extracorporeal life support and continuous renal replacement therapy in a patient with Enterovirus A71 associated cardiopulmonary failure: A case report

    by Nguyen Trung Bao, Vo Thanh Luan, Bui Thanh Liem, Vo Hoang Thien Msc Nhu, Do Chau Viet, Trinh Huu Tung, Sakib Burza, Nguyen Tat Thanh

    Rationale: Hand-foot-mouth disease (HFMD) caused by Enterovirus A71, complicated by cardiopulmonary failure, is associated with a high mortality rate despite intensive treatment. To date, there is a paucity of clinical management data, regarding the use of extracorporeal life support (VA-ECMO) for Enterovirus-A71 associated cardiopulmonary failure reported. Patient concerns: The patient in this study presented with severe HFMD complicated by cardiopulmonary failure, polymorphic ventricular tachycardia, and cardiac arrest. Diagnoses: Clinical presentations, laboratory data, and polymerase chain reaction (PCR) results from rectal swabs were used to confirm the diagnosis of severe HFMD caused by Enterovirus A71. Interventions: The patient was managed with chest compression and an automatic external defibrillator, mechanical ventilation, intravenous immunoglobulin (IVIG), continuous renal replacement therapy (CRRT) and inotrope (milrinone). The patient did not respond to these interventions and subsequently required further management with VA-ECMO. Outcomes: The patient achieved a favorable outcomes. Lessons: Our study highlights that extracorporeal membrane oxygenation and CRRT can enhance the survival outcomes of patients with severe HFMD with cardiopulmonary failure complications. Furthermore, we propose specific indications for the initiation of VA-ECMO.


  • Open Access

    Antibiotic susceptibility patterns of pathogens isolated from hospitalized patients with advanced HIV disease (AHD) in Bihar, India

    by Vikash Kumar, Shreyas Murali, Jacob Goldberg, Beatriz Alonso, Laura Moretó-Planas, Anthony Reid, Amit Harshana, Sakib Burza, Raman Mahajan

    To describe the prevalence of common bacterial pathogens and antibiotic susceptibility patterns amongst advanced HIV disease (AHD) patients admitted between May 2019 and March 2021 to a Médecins Sans Frontières (MSF)-supported AHD inpatient unit in Bihar, India. A retrospective analysis of routinely collected demographic, clinical and microbiological data. Antibacterial susceptibility testing was done by an accredited referral laboratory using the modified Kirby–Bauer disc diffusion method. A total of 238 isolates from 577 patients were identified through culture testing. Patient median (IQR) age was 38 (31–45) years, and 75% were male. Predominant sample types included blood (600; 38%), urine (266; 17%) and sputum (178; 11%). Of the isolated bacteria, Escherichia coli (80; 13.9%) was the most prevalent, followed by Klebsiella pneumonia (54; 9.4%), Pseudomonas aeruginosa (22; 3.8%), Klebsiella oxytoca (10; 1.7%), Proteus mirabilis (9; 1.6%), and Acinetobacter baumannii (7; 1.2%). The resistance pattern showed that most bacterial isolates were highly resistant to commonly prescribed antibiotics such as third-generation cephalosporins, fluoroquinolones and co-trimoxazole. Most pathogens were moderately resistant to antibiotics from the WHO Watch group, such as meropenem and piperacillin/tazobactam. In contrast, isolates were more susceptible to aminoglycosides, such as amikacin, gentamicin and nitrofurantoin. In Bihar, inpatients with AHD displayed a concerning array of antibiotic-resistant infections. This study provides a starting point from which further work on antimicrobial resistance in this vulnerable cohort of patients can be conducted.


  • Open Access

    Source tracing of Leishmania donovani in emerging foci of visceral leishmaniasis in West Nepal

    by Pieter Monsieurs, Kristien Cloots, Surendra Uranw, Megha Raj Banjara, Prakash Ghimire, Sakib Burza, Epco Hasker, Jean-Claude Dujardin, Malgorzata Anna Domagalska

    We sequenced Leishmania donovani genomes in blood samples collected in emerging foci of Visceral Leishmaniasis, in West Nepal. We detected lineages which are very different from pre-elimination main parasite population: a new lineage and a rare one previously reported once in East Nepal. We highlight the need for genomic surveillance.

  • Open Access

    Doing our best and doing no harm: A focused ethnography of staff moral experiences of providing palliative care at a Médecins Sans Frontières pediatric hospital in Cox’s Bazar, Bangladesh

    by Rachel Yantzi, Hadiuzzaman, Pradip Kumar Sen Gupta, Amin Lamrous, Kathryn Richardson, John Pringle, Lisa Schwartz, Puspita Hossain, David Kizito, Sakib Burza

    Introduction: The Médecins Sans Frontières (MSF) Goyalmara Hospital in Cox’s Bazar, Bangladesh is a referral centre offering the highest level of care available in the Rohingya camps for pediatrics and neonatology. Efforts are underway to integrate pediatric palliative care due to high mortality and medical complexity of patients, yet little is known about the experiences of staff delivering palliative and end-of-life care. The purpose of this study was to understand the moral experiences of MSF staff to inform program planning and implementation. Methods: This focused ethnography was conducted between March-August 2021 at Goyalmara Hospital. Data collection involved participant-observation, individual interviews (22), focus group discussions (5), and analysis of documents including MSF clinical guidelines, admission and referral criteria, reports, and training materials. Data analysis followed a modified version of the Qualitative Analysis Guide of Leuven and data were coded using NVivo software. Results: The prevailing understanding of pediatric palliative care among national and international staff was care that prioritized comfort for infants and children who were not expected to survive. Staff’s views were informed by their sense of obligation to do no harm, to do their best on behalf of their patients, and religious beliefs about God’s role in determining the child’s outcome. The authority of doctors, international staff, as well as protocols and guidelines shaped palliative care decision-making. Staff saw clinical guidelines as valuable resources that supported a consistent approach to care over time, while others were concerned that palliative care guidelines were rigidly applied. Conclusion: When integrating palliative care into humanitarian programs, it is important to emphasize the active role of palliative care in reducing suffering. Advocacy for access to the highest level of care possible should continue alongside palliative care integration. While palliative care guidelines are valuable, it is essential to encourage open discussion of staff concerns and adapt care plans based on the family’s needs and preferences.


  • Open Access

    Progression of asymptomatic Leishmania infection to visceral leishmaniasis in HIV-positive individuals in Bihar, India

    by Raman Mahajan, Sophie I. Owen, Shiril Kumar, Krishna Pandey, Shahwar Kazmi, Vikash Kumar, Emily R. Adams, Amit Harshana, Sakib Burza

    There are no data on rate and risk factors for progression from asymptomatic Leishmania infection (ALI) to visceral leishmaniasis (VL) in people living with HIV (PLHIV) on the Indian subcontinent. In this prospective cohort study, we aim to establish the rate and risk factors for progression of ALI to VL in a cohort of PLHIV in Bihar, India. We identified 108 PLHIV having ALI at baseline (rK39 enzyme-linked immunosorbent assay (ELISA) and/or rK39 rapid diagnostic test (RDT) and/or quantitative polymerase chain reaction (qPCR); in addition, the urinary Leishmania antigen ELISA was evaluated). The cohort was followed up every three months for 18 months in person; four (3.7%) participants developed VL. All four progressors to VL were positive by a minimum of three of the four tests in combination and had high levels of antigenuria and anti- Leishmania antibody titers compared to ALI non-progressors. The overall risk of developing VL in ALI diagnosed by rK39 ELISA, rK39 RDT, qPCR, and Leishmania antigen ELISA was 3.7% (4/108), 40% (2/5), 57% (4/7) and 50% (4/8), respectively. A secondary analysis was conducted on a cohort of 1198 PLHIV without ALI at baseline residing in the same areas, who were followed up by telephone for 18 months. All-cause mortality was higher in ALI compared to non-ALI (odds ratio (OR)=2.7; 95% confidence intervals (CI): 1.1-6.1). In multivariate modelling combining both cohorts, low CD4 counts, being clinical stage III for HIV infection as per World Health Organization (WHO) classification, and not being on anti-retroviral therapy (ART) at baseline were significantly associated with mortality, while ALI was not. There is a low rate of progression from ALI to VL in PLHIV. Individuals with ALI have higher mortality than those without, however, ALI was not a statistically significant factor for mortality after adjusting for other factors in a multivariate model. Author summary: People living with HIV (PLHIV) are at higher risk of developing visceral leishmaniasis (VL) and poor associated outcomes. We followed a cohort of 108 PLHIV in India with asymptomatic Leishmania infection (ALI) identified at baseline for 18 months to establish the rate and risk factors for progression of ALI to VL. ALI was defined as a positive rK39 enzyme-linked immunosorbent assay (ELISA) and/or rK39 rapid diagnostic test (RDT) and/or quantitative polymerase chain reaction (qPCR). Additionally, the urinary Leishmania antigen ELISA was evaluated. Within the 18-month follow-up period, four (3.7%) individuals developed VL, all positive by at least three of the four tests in combination at baseline and had high levels of antigen in the urine and anti- Leishmania antibody titers compared to ALI non-progressors. As a secondary analysis, we followed up a cohort of 1198 PLHIV without ALI from the same area by telephone over the same 18-month period. Mortality associated with any cause was higher in those with ALI compared to non-ALI. Across both ALI and non-ALI cohorts, low CD4 counts, being clinical stage three for HIV infection according to the World Health Organization (WHO) classification (one to four), and not being on anti-retroviral therapy (ART) at baseline were significantly associated with mortality.